As of April 18, 2025, Matinas BioPharma (MTNB) has a market cap of $3.052 million USD. According to our data, Matinas BioPharma is ranked No.9108 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $3.05 M |
17.65%
|
Dec 31, 2024 | $2.59 M |
-95.28%
|
Dec 29, 2023 | $54.94 M |
-56.80%
|
Dec 30, 2022 | $0.13 B |
-50.50%
|
Dec 31, 2021 | $0.26 B |
-25.74%
|
Dec 31, 2020 | $0.35 B |
-40.09%
|
Dec 31, 2019 | $0.58 B |
281.51%
|
Dec 31, 2018 | $0.15 B |
-48.71%
|
Dec 29, 2017 | $0.30 B |
-17.14%
|
Dec 30, 2016 | $0.36 B |
64.71%
|
Dec 31, 2015 | $0.22 B |
88.89%
|
Dec 31, 2014 | $0.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amarin Corporation
AMRN
|
$0.19 B |
-0.000 M
|
![]() Ireland
|
![]() Acasti Pharma
ACST
|
$34.17 M |
-3.448 M
|
![]() Canada
|
![]() Corbus Pharmaceuticals
CRBP
|
$73.76 M |
0.000 M
|
![]() USA
|
![]() Lipocine
LPCN
|
$16.05 M |
0.000 M
|
![]() USA
|
![]() Esperion Therapeutics
ESPR
|
$0.19 B |
0.000 M
|
![]() USA
|
![]() Arrowhead Pharmaceuticals
ARWR
|
$1.54 B |
-0.000 M
|
![]() USA
|
![]() Viking Therapeutics
VKTX
|
$2.69 B |
-0.000 M
|
![]() USA
|
![]() Akebia Therapeutics
AKBA
|
$0.54 B |
0.000 M
|
![]() USA
|
![]() Omeros Corporation
OMER
|
$0.39 B |
-0.000 M
|
![]() USA
|
![]() Spero Therapeutics
SPRO
|
$42.16 M |
0.011 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.35 B |
0.000 M
|
![]() USA
|
Market Cap | = | MTNB Stock Price | * | MTNB Shares Outstanding |
= | $0.60 | * | 5.09 M | |
= | $3.05 M |